ADVERTISEMENT

Emcure Pharma IPO Allotment Today; How To Check Share Allotment Status?

The IPO of Emcure Pharmaceuticals Limited was subscribed 67.87 times on the final day of bidding. The allotment of the IPO will be finalised today.

<div class="paragraphs"><p>The Emcure Pharma IPO was subscribed 67.87 times as of 7 p.m. on Friday. (Source: Emcure Pharmaceuticals/Facebook)</p></div>
The Emcure Pharma IPO was subscribed 67.87 times as of 7 p.m. on Friday. (Source: Emcure Pharmaceuticals/Facebook)

On the last day of bidding for the Emcure Pharma IPO, the issue was subscribed to 67.87 times led by Institutional investors who subscribed to the issue 195.83 times. Retail investors subscribed 7.21 times, Non-institutional investors subscribed 48.32 times and Employee reserved category investors subscribed 8.81 times.

The initial public offering of Emcure Pharmaceutical Ltd.'s Rs 1,952 crore initial public offering comprises a fresh issue of up to Rs 800 crore and an offer for sale of 1.14 crore equity shares.

The IPO, a book-built issue concluded its subscription period on July 5. The Bain Capital-backed company has set a price band of Rs 960–1,008 per share for its IPO. At the upper end of the price band, the market value stands at Rs 19,060 crore. Retail investors had a minimum investment requirement of Rs 14,112 for 14 shares.

The allotment for Emcure Pharma IPO will be finalised on Monday, July 8.

Investors can check the status of Emcure Pharma's IPO allotment on Link Intime India Private Ltd and BSE website.

Steps to check Emcure Pharma IPO allotment status on Link Intime India

  • Visit the official website of Link Intime India Private Limited: https://linkintime.co.in/Initial_Offer/public-issues.html

  • Select the IPO name "Emcure Pharmaceuticals Limited" from the drop-down menu. (Name will be populated only if the allotment is finalised).

  • Choose one of the three options: Application number, Demat Account number, or PAN ID.

  • Provide the relevant details of the selected mode.

  • Click on the "Search" button.

  • View your allotment details.

  • Download/print the allotment status for your records.

Steps to check Emcure Pharma IPO allotment status on BSE

  • Visit the official BSE website: bseindia.com/investors/appli_check.aspx

  • Click on "Equity" under "Issue Type."

  • Select "Emcure Pharmaceuticals Limited" from the IPO list.

  • Enter your application number or PAN number.

  • Complete the 'Captcha.'

  • Click on the "Search" button to view your allotment status.

  • Download/print the allotment status for your records.

Listing date of Emcure Pharmaceuticals Limited

Emcure Pharma IPO will be listed on BSE and the National Stock Exchange with a tentative listing date set for Wednesday, July 10.

Emcure Pharma IPO Important Dates

  • IPO Open Date: Wednesday, July 3

  • IPO Close Date: Friday, July 5

  • Basis of Allotment: Monday, July 8

  • Initiation of Refunds: Tuesday, July 9

  • Credit of Shares to Demat: Tuesday, July 9

  • Listing Date: Wednesday, July 10

The IPO of Emcure Pharmaceuticals was the 16th most subscribed IPO of this year.

About Emcure Pharma Limited

Emcure Pharmaceuticals Limited, an Indian company founded in 1981, is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company has more than 350 brands, five research and development centres, and 14 manufacturing facilities across India, as per information on its website. It sells in over 70 countries with a strong presence in India, Europe and Canada.

The company is focused towards pharmaceutical products used in chronic therapeutic areas and has been granted 220 patents and has 30 pending patent applications in several countries. It had submitted 102 drug master files for APIs with the US Food and Drug Administration.

BC Investments IV Ltd., an affiliate of US-based private equity major Bain Capital, will be among the selling shareholders in the OFS, with 72.34 lakh shares to offload. Kotak Mahindra Capital Co., Axis Capital Ltd., Jefferies India Pvt. and JPMorgan India Pvt. are the issue's book-running lead managers.